NI Technology Updates Outlooks for Applied Micro Circuits, Broadcom, Cavium, EZchip Semiconductor, and MIPS Technologies
13 Apr, 2012, 09:57 ET
PRINCETON, N.J., April 13, 2012 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), an online investment newsletter focused on semiconductor and technology stocks, has published updated outlooks for Applied Micro Circuits (Nasdaq: AMCC), Broadcom (Nasdaq: BRCM), Cavium (Nasdaq: CAVM), EZchip Semiconductor (Nasdaq: EZCH), and MIPS Technologies (Nasdaq: MIPS).
Editor Paul McWilliams spent a decades-long career in the technology industry, and has earned a reputation for his skill at communicating complex technology trends to individual investors and professional analysts alike. His reports have won over readers with their ability to unravel the complexities of the industry and, more importantly, identify which companies are likely to be the winners and losers as technology trends change.
Next Inning is now publishing its highly acclaimed, multi-part State of Tech Report covering the technology sector from semiconductor wafer fabrication through finished goods and representing nearly a trillion dollars in annual revenue. This breadth provides investors with unique visibility across an array of sectors and for years this quarterly report has given Next Inning subscribers the opportunity to find hidden gems before they are discovered by Wall Street.
The latest 40-page installment of the State of Tech report covers semiconductor companies that power the broadband connectivity behind the mobile computing boom. Out of the nine stocks covered in the Specialty Semiconductor State of Tech, only one closed on April 12th down from where it started the year. It is the only stock out of the nine that McWilliams said investors should avoid buying in his December 30th, 2011 installment of the report. Only two of the stocks were listed as good strategic investments. Those two stocks have delivered an average year-to-date return of 41%; more than double the 19% average for the entire group. The latest update to this report includes McWilliams' critical insights on which stocks will be the big winners over the next several months.
To get ahead of the Wall Street curve and receive Next Inning's latest reports for free, you are invited to take a free, 21-day, no obligation trial with Next Inning. For full details on this offer, please visit the following link:
McWilliams covers these topics and more in his latest reports:
-- Has the Applied Micro turnaround story been derailed or just stalled temporarily? McWilliams says it's best to view Applied Micro in two pieces; one is a profitable broadband infrastructure company, and the other is a venture capital investment that is not yet shipping a product but has a huge jump on the competition in the ARM Holdings server market. How does McWilliams think these two pieces should be valued and what price does he think Applied Micro would trade for if the venture capital aspect of the story was better understood?
-- Given the fact that McWilliams wrote that Broadcom needed to buy either Cavium or NetLogic two months before the company announced it would acquire the latter, you have to assume he likes the acquisition. He punctuated that call by suggesting readers consider buying Broadcom in his last two State of Tech reports. However, McWilliams is a fundamentalist with a keen eye for value, and with the price of Broadcom up sharply from where he thought it was a good buy last fall in the $20s, you'll want his most current take before letting your guard down ahead of its upcoming quarterly report. One important consideration is what he thinks Broadcom's balance sheet will look like with the NetLogic acquisition now completed – would he buy, sell or hold today?
-- What two factors are behind Cavium's success in building strong design momentum? Is there a way to quantify Cavium's design base and explain why it is taking so long to produce revenue? Should investors be concerned that Wall Street's patience with Cavium is wearing thin? Is Cavium trading at a bargain price following the recent dip or should investors wait for a sharper pullback before adding shares?
-- McWilliams says EZchip is one of the few small-cap tech stocks that merits consideration as a "strategic" investment. What two factors are masking EZchip's revenue growth? What is McWilliams projection for EZchip's revenue and earnings in 2015 and what gives him the confidence to forecast out three years in the future? Is EZchip well positioned to continue its strong growth trajectory? How might Marvell's acquisition of EZchip competitor Xelerated impact EZchip? Are Wall Street's forecasts for EZchip way too low? Does McWilliams' in depth valuation analysis suggest that EZchip shares could be worth over $60 this year?
-- What does McWilliams make of recent reports that MIPS may be an acquisition target? Why are patents the key driver behind any potential deal? What other interesting strategy might MIPS consider executing to release the value of its patent portfolio?
Founded in September 2002, Next Inning's model portfolio has returned 301% since its inception versus 53% for the S&P 500.
About Next Inning:
Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks. Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.
NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515
SOURCE Indie Research Advisors, LLC
Share this article